About admin

This author has not yet filled in any details.
So far admin has created 115 blog entries.

Organogenesis to Sponsor Jan. 30 Webinar, “Chronic Wounds and Biofilms: Advancing Assessment and Treatment,” Featuring Dr. Gregory Schultz

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, will sponsor a January 30 WoundSource webinar, "Chronic Wounds and Biofilms: Advancing Assessment and Treatment" led by Gregory Schultz, PhD, Professor of Obstetrics and Gynecology and Director of the Institute for Wound Research at the University of Florida. Click here to read the full article.

By |2019-02-19T16:17:03+00:00January 24th, 2019|News|Comments Off on Organogenesis to Sponsor Jan. 30 Webinar, “Chronic Wounds and Biofilms: Advancing Assessment and Treatment,” Featuring Dr. Gregory Schultz

The Time Obsessed Consumer: Study Reveals Impact on Brands Now that Time is the New Currency

Allen & Gerritsen survey shows that to today’s consumer, the relationship between time and money is more complicated than ever. Taking a look at consumer's relationship with time, which is more fleeting than ever, especially in light of technology designed to make lives easier. Click here to read the full article.

By |2019-02-19T15:28:13+00:00January 18th, 2019|News|Comments Off on The Time Obsessed Consumer: Study Reveals Impact on Brands Now that Time is the New Currency

Organogenesis Holdings Inc. Receives Positive Nasdaq Listing Determination

Class A Common Stock to Resume Trading on Nasdaq Organogenesis Holdings Inc. (the "Company") (Nasdaq: ORGO; ORGOW) today announced that on January 4, 2019, the Company was notified by The Nasdaq Stock Market LLC ("Nasdaq") that, based on the plan of compliance presented by the Company at its hearing, the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for the continued listing of its Class A common stock on The Nasdaq Capital Market. Pursuant to the Panel's decision, on [...]

By |2019-02-19T16:19:46+00:00January 7th, 2019|News|Comments Off on Organogenesis Holdings Inc. Receives Positive Nasdaq Listing Determination

Exergen Reduces Hospital Costs by 90%

Exergen Corporation has announced that two new studies from Postgraduate Medical Journal indicate that when used throughout a hospital, Exergen TemporalScanners deliver substantial cost savings while providing accuracy and ease of use, as supported by more than 70 peer-reviewed published studies for all ages and clinical settings. Click here to read the full article.

By |2019-03-12T19:53:20+00:00December 28th, 2018|News|Comments Off on Exergen Reduces Hospital Costs by 90%

Exergen’s Sensors Help Develop A Solution To Ensure Safe Blood Transfusions

Exergen Global Joins with SCB to help it Conquer Complexity in Building Fluid Infusion Systems that Maintain Precise Temperatures of Blood Products Exergen Global today announced that its Micro IRt/c-HB infrared non-contact sensors are being used to measure blood product… Click here to read the full article.

By |2019-03-12T20:07:05+00:00November 2nd, 2018|News|Comments Off on Exergen’s Sensors Help Develop A Solution To Ensure Safe Blood Transfusions

University Medical Centre Groningen Chooses TAT-5000 of Exergen Medical as Standard Thermometer Throughout The Hospital

University Medical Centre Groningen has decided to standardize on the TAT-5000 thermometer of Exergen Medical. The well-known university hospital – based in Groningen, The Netherlands – will buy several hundreds of the ‘temporal scanner’ from the Dutch distributor, Van Vliet Medical Products. Click here to read the full article.

By |2019-03-12T20:08:33+00:00November 2nd, 2018|News|Comments Off on University Medical Centre Groningen Chooses TAT-5000 of Exergen Medical as Standard Thermometer Throughout The Hospital

Dynasil Corporation Announces Addition of RMD to Corporate Website

Dynasil Corporation of America (NASDAQ:DYSL), a developer and manufacturer of optics and photonics products, optical detection and analysis technology and components for the homeland security, industrial, medical, and biotech markets, is pleased to announce its latest website upgrade and the availability of additional information and products at www.dynasil.com. Content previously available on Radiation Monitoring Devices’s (RMD’s) website has been updated and added to the corporate website. Click here to read the full article.

By |2019-02-19T16:13:54+00:00October 25th, 2018|News|Comments Off on Dynasil Corporation Announces Addition of RMD to Corporate Website

Introducing the NEW D501LN, Handheld Scanner Featuring the Extended Nosepiece for Safety and Ease of Use

New Scanner Includes all Features Found in DX501 Exergen Global today introduced the D501LN, a handheld certified infrared scanner that provides all the features found in Exergen’s DX501, with an extended nosepiece to enhance safety and ease-of-use.  Click here to read the full article.

By |2019-03-12T20:09:58+00:00October 18th, 2018|News|Comments Off on Introducing the NEW D501LN, Handheld Scanner Featuring the Extended Nosepiece for Safety and Ease of Use